New Delhi: Gambia on Thursday urgently recalled Indian-made cough syrup linked to the death of 66 children.

Speaking to news agency The Associated Press, the Director of Health Dr. Mustapha Bittaye confirmed the wave of child deaths from acute kidney injury, sending shockwaves across the country of 2.4 million people and around the world.

The Indian government today initiated a probe into the manufacturing of four cough syrups by a Haryana-based pharmaceutical firm after an alert was issued by the World Health Organization (WHO).

Also Read: Russian Defence Ministry report on the progress of the special military operation in Ukraine

The news agency PTI quoted a source saying, “While all required steps will be taken, as a robust regulatory authority, WHO has been requested to share with CDSCO (Central Drugs Standard Control Organisation) the earliest the report on the establishment of a causal relation to the deaths with the medical products in question, photographs of labels/products etc.”

The WHO stated that the syrups could be linked to death of 66 children in the Gambia. It added that the manufacturer has not provided guarantees to WHO on the safety and quality of these products.

Also Read: Zelenskyy urges NATO for ‘pre-emptive strikes’ to ‘eliminate possibility’ of Russian nuclear strikes

“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions,” said the WHO.

The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

Read More :- Latest World News